MedPath

The effects of aroma Citrus aurantium L. on sleep quality in heart patients

Phase 1
Conditions
Heart Disease.
Ischemic Heart Disease
120-121-12
Registration Number
IRCT2013121415789N1
Lead Sponsor
Vice chancellor for research, Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Hospitalized patients with the Clinical diagnosis of heart disease in intensive coronary care unit.
Having a strong natural tendency for cooperation in doing some medical research and signing the Informed Consent form for research.
Stable vital signs ((blood pressure, pulse, respiration, temperature)
Patients aged over 18 and under 65.
Patients with no medical histories of mental illness having led to a long period hospitalization and the consumption of psychiatric drugs.
No use of herbal medicines in the past two weeks.
Having no allergic histories to medicines and all herbs (Herbal Medicines or Herbal remedies)
No allergy symptoms were caused about all the medicines they had taken in the allergy tests.
Positive indicators of Epworth Questionnaire (score>5)
To have taken Berlin questionnaire for sleep apnea” to be positive.

Exclusion Criteria

Vital sign instability which leads to a change in drug instructions.
Dosage change and the sedative drugs deletion, if desired.
The transference of patients from the Cardiac Care Unit to the other wards.
To be discharged from the hospital –doctor’s orders or against medical advice.
To display no tendencies to cooperate on the research any longer.
Allergy symptoms are to be caused.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep Quality. Timepoint: 2 hours preintervention - 3 days post intervention. Method of measurement: St Marry's Hospital Sleep Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Sensitivity to Citrus Aurantium L. essence. Timepoint: 2 hours preintervention- every 3 hours during intervention and 2 hours post intervention. Method of measurement: Clinical signs and symptoms.
© Copyright 2025. All Rights Reserved by MedPath